Multidrug-resistant bacteria are an urgent global concern, affecting both developed countries with thousands of annual deaths and billions in healthcare costs, and it is also a leading cause of death in developing countries. This issue arises due to the inefficient diagnosis of infections and the misuse of broadspectrum antibiotics . Some of the pathogens that require urgent research for the development of new antimicrobial agents include the ESKAPE pathogens-E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, and Enterobacter species-. These bacteria are known for their ability to evade the effects of antibiotics and significantly contribute to healthcare-associated infections.